Most Anticipated Earnings: CYM-X, BB-T and more Canadian Companies Reporting Earnings this Week (Dec 16-20)

(A Top Pick Jan 14/21, Up 35.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI has triggered its stop at $3.00. We recommend covering the balance of the position at this time. When combined with the previous recommendation to cover half the position, this results in a net investment gain over 46%.

Metal foam technology. Have an application where they can put it into armoured vehicles for blast disbursement. Also have some small deals on the architectural side. In this environment he doesn't think people will be paying a whole lot of attention to it.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research As a developer, it comes down to the quality of CRE's assets. It has $40M cash, but no revenue, losses and negative cash flow. Insiders own 4.5% and management looks good (the CEO sold Rockwood for $6B). Its Rose Project (Quebec) is quite attractive, with…

Fairly substantial discount to market cap of its portfolio, and you get the company's own asset base for free. He's a really big fan of free. Yes, this is a way to buy NXE cheaper.Price of uranium doesn't really need to go up, as it's above the incentive price. What's really changed in uranium is…

Azimut (AZM-X) and Eastmain (ER-T) just announced some results if you are interested in the Eleonor, James Bay region.

It is a small player in the cyber securities market related to Ransom Ware. It had decent revenue in the last year and is finally making money. However it doesn't have much of a runway left. It is a volatile stock in a crowded market.

For this one, he's looking at the very right side of a 1-year chart. You can see the basing, but what you want to see is a breakout. Could be a swing trade, but doesn't really have enough movement to do that. Could go sideways forever, or break to the downside. Don't buy until you…

He would hope this will be a global breakthrough. The basic processes involved are dealing with Wi-Fi as it goes into the destruct phase because of too much crowding. This company has created a diversionary stream of traffic. It is looking more interesting.

BF-N vs. CE-X. BASF is the world's largest chemical company. It sells at a high premium. There is concern that prices are too high to last.

Very positive on the stock price, the company, and the partnerships they're announcing. Technicals indicate the stock may head toward 90 cents, but he says higher. Just won a contract from the Ontario government. Covid testing isn't going away. Sales should triple in the next 12 months.

In Canada, this smallcap (C$210 million) biotech in Halifax submitted its antibody test to the FDA. Since April 22, MedMira has soared from 6 cents/share to over 30. There's scant coverage or even stock metrics to report. Also MedMira is one of many companies to submit such tests to the FDA, but it's worth keeping…